Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

MiR-192 inhibits nucleotide excision repair by targeting ERCC3 and ERCC4 in HepG2.2.15 cells.

Xie QH, He XX, Chang Y, Sun SZ, Jiang X, Li PY, Lin JS.

Biochem Biophys Res Commun. 2011 Jul 8;410(3):440-5. doi: 10.1016/j.bbrc.2011.05.153. Epub 2011 Jun 6.

PMID:
21672525
2.

Altered expression profiles of microRNAs in a stable hepatitis B virus-expressing cell line.

Liu Y, Zhao JJ, Wang CM, Li MY, Han P, Wang L, Cheng YQ, Zoulim F, Ma X, Xu DP.

Chin Med J (Engl). 2009 Jan 5;122(1):10-4.

PMID:
19187610
3.

Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210.

Zhang GL, Li YX, Zheng SQ, Liu M, Li X, Tang H.

Antiviral Res. 2010 Nov;88(2):169-75. doi: 10.1016/j.antiviral.2010.08.008. Epub 2010 Aug 20.

PMID:
20728471
4.

Newly identified CHO ERCC3/XPB mutations and phenotype characterization.

Rybanská I, Gursky J, Fasková M, Salazar EP, Kimlícková-Polakovicová E, Kleibl K, Thompson LH, Pirsel M.

Mutagenesis. 2010 Mar;25(2):179-85. doi: 10.1093/mutage/gep059. Epub 2009 Nov 25.

5.

MicroRNA regulation of DNA repair gene expression in hypoxic stress.

Crosby ME, Kulshreshtha R, Ivan M, Glazer PM.

Cancer Res. 2009 Feb 1;69(3):1221-9. doi: 10.1158/0008-5472.CAN-08-2516. Epub 2009 Jan 13. Erratum in: Cancer Res. 2009 Apr 1;69(7):3240.

6.

The hepatitis B virus-associated estrogen receptor alpha (ERalpha) was regulated by microRNA-130a in HepG2.2.15 human hepatocellular carcinoma cells.

Tang L, Pu Y, Wong DK, Liu T, Tang H, Xiang T, Yuen MF, Ren G.

Acta Biochim Biophys Sin (Shanghai). 2011 Aug;43(8):640-6. doi: 10.1093/abbs/gmr051. Epub 2011 Jun 28.

PMID:
21712254
7.

Characterization of illudin S sensitivity in DNA repair-deficient Chinese hamster cells. Unusually high sensitivity of ERCC2 and ERCC3 DNA helicase-deficient mutants in comparison to other chemotherapeutic agents.

Kelner MJ, McMorris TC, Estes L, Rutherford M, Montoya M, Goldstein J, Samson K, Starr R, Taetle R.

Biochem Pharmacol. 1994 Jul 19;48(2):403-9.

PMID:
8053936
8.

Deficiency in nucleotide excision repair family gene activity, especially ERCC3, is associated with non-pigmented hair fiber growth.

Yu M, Bell RH, Ho MM, Leung G, Haegert A, Carr N, Shapiro J, McElwee KJ.

PLoS One. 2012;7(5):e34185. doi: 10.1371/journal.pone.0034185. Epub 2012 May 16.

9.

Clinical heterogeneity within xeroderma pigmentosum associated with mutations in the DNA repair and transcription gene ERCC3.

Vermeulen W, Scott RJ, Rodgers S, Müller HJ, Cole J, Arlett CF, Kleijer WJ, Bootsma D, Hoeijmakers JH, Weeda G.

Am J Hum Genet. 1994 Feb;54(2):191-200.

10.

The role of glutathione in the regulation of nucleotide excision repair during oxidative stress.

Langie SA, Knaapen AM, Houben JM, van Kempen FC, de Hoon JP, Gottschalk RW, Godschalk RW, van Schooten FJ.

Toxicol Lett. 2007 Feb 5;168(3):302-9. Epub 2006 Nov 16.

PMID:
17207589
11.

Nucleotide excision repair functions in the removal of chromium-induced DNA damage in mammalian cells.

O'Brien TJ, Brooks BR, Patierno SR.

Mol Cell Biochem. 2005 Nov;279(1-2):85-95.

PMID:
16283517
12.

Optimization of a microRNA expression vector for function analysis of microRNA.

Furukawa N, Sakurai F, Katayama K, Seki N, Kawabata K, Mizuguchi H.

J Control Release. 2011 Feb 28;150(1):94-101. doi: 10.1016/j.jconrel.2010.12.001. Epub 2010 Dec 10.

PMID:
21146569
13.

Mouse model for the DNA repair/basal transcription disorder trichothiodystrophy reveals cancer predisposition.

de Boer J, van Steeg H, Berg RJ, Garssen J, de Wit J, van Oostrum CT, Beems RB, van der Horst GT, van Kreijl CF, de Gruijl FR, Bootsma D, Hoeijmakers JH, Weeda G.

Cancer Res. 1999 Jul 15;59(14):3489-94.

14.

Nucleotide excision repair is not required for the antiapoptotic function of insulin-like growth factor 1.

Lee-Kwon W, Park D, Bernier M.

Exp Cell Res. 1998 Jun 15;241(2):458-66.

PMID:
9637787
15.

MicroRNA-141 represses HBV replication by targeting PPARA.

Hu W, Wang X, Ding X, Li Y, Zhang X, Xie P, Yang J, Wang S.

PLoS One. 2012;7(3):e34165. doi: 10.1371/journal.pone.0034165. Epub 2012 Mar 30. Erratum in: PLoS One. 2012;7(7). doi:10.1371/annotation/cbbe9454-0b72-44b3-a972-10dcaf22db68.

16.
17.

Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer.

Arndt GM, Dossey L, Cullen LM, Lai A, Druker R, Eisbacher M, Zhang C, Tran N, Fan H, Retzlaff K, Bittner A, Raponi M.

BMC Cancer. 2009 Oct 20;9:374. doi: 10.1186/1471-2407-9-374.

18.

ERCC4 (XPF) encodes a human nucleotide excision repair protein with eukaryotic recombination homologs.

Brookman KW, Lamerdin JE, Thelen MP, Hwang M, Reardon JT, Sancar A, Zhou ZQ, Walter CA, Parris CN, Thompson LH.

Mol Cell Biol. 1996 Nov;16(11):6553-62.

19.

Excision repair cross complementing 3 expression is involved in patient prognosis and tumor progression in esophageal cancer.

Terashita Y, Ishiguro H, Haruki N, Sugiura H, Tanaka T, Kimura M, Shinoda N, Kuwabara Y, Fujii Y.

Oncol Rep. 2004 Oct;12(4):827-31.

PMID:
15375507
20.

miR-181a and miR-630 regulate cisplatin-induced cancer cell death.

Galluzzi L, Morselli E, Vitale I, Kepp O, Senovilla L, Criollo A, Servant N, Paccard C, Hupé P, Robert T, Ripoche H, Lazar V, Harel-Bellan A, Dessen P, Barillot E, Kroemer G.

Cancer Res. 2010 Mar 1;70(5):1793-803. doi: 10.1158/0008-5472.CAN-09-3112. Epub 2010 Feb 9.

Items per page

Supplemental Content

Write to the Help Desk